The concurrent use of Rhus verniciflua stokes as complementary therapy with second or more line regimen on advanced non-small-cell lung cancer: case series
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.